Consistent with its expression being associated with fibroblast quiescence [11], CCN3 elicits an inhibitory effect in normal and pathological conditions, including tumour-derived cells in which high CCN3 levels are detected and associated with higher proliferation rates and/or high tumourigenic potential [7,11,24,29,30]. The gene discussed is CCN3; the disease is neoplasm.